Katarzyna Korczak

Title: Katarzyna Korczak: Innovator in Pharmaceutical Chemistry

Introduction

Katarzyna Korczak is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. Her work has led to the filing of a patent that showcases her innovative approach to drug formulation.

Latest Patents

Katarzyna holds 1 patent related to her research on crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention focuses on the methanesulfonic acid addition salts of Imatinib and their synthesis. Specifically, it details the synthesis of the crystalline α-form of Imatinib methanesulfonate. Additionally, the patent introduces a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid, along with its polymorphic forms and pharmaceutical compositions.

Career Highlights

Katarzyna has established herself as a key figure in her field through her innovative research and dedication to advancing pharmaceutical sciences. Her work at the Instytut Farmaceutyczny has been instrumental in developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout her career, Katarzyna has collaborated with notable colleagues, including Wojciech Szczepek and Dorota Samson-Lazinska. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Katarzyna Korczak's contributions to pharmaceutical chemistry exemplify the impact of innovative research on drug development. Her patent on Imatinib methanesulfonate showcases her commitment to advancing medical science and improving therapeutic options.